Invention Grant
- Patent Title: Intranasal vaccination dosage regimen
-
Application No.: US14650831Application Date: 2013-12-17
-
Publication No.: US09700614B2Publication Date: 2017-07-11
- Inventor: Hans Arwidsson , Anna-Karin Maltais
- Applicant: Eurocine Vaccines AB
- Applicant Address: SE Solna
- Assignee: Eurocine Vaccines AB
- Current Assignee: Eurocine Vaccines AB
- Current Assignee Address: SE Solna
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: DK201270788 20121217
- International Application: PCT/EP2013/076905 WO 20131217
- International Announcement: WO2014/095866 WO 20140626
- Main IPC: A61K39/145
- IPC: A61K39/145 ; A61K39/12 ; A61K39/39 ; A61K39/00

Abstract:
The present invention relates in a first aspect to a vaccine kit comprising a) a first vaccine component comprising i) a first set of one or more containers, each container containing a vaccine composition for intranasal administration, b) optionally a second vaccine component comprising a second set of one or more containers, each container containing a vaccine composition for intranasal administration, and c) optionally instructions for use, wherein each container of the first and second set of containers contains a volume of the vaccine composition from about 5 microliter to about 400 microliter. The present invention also relates to: An administration regimen for intranasal administration of a vaccine composition for use in immunizing a human. A device for use in administration of vaccine compositions. The use of: a) a first vaccine component comprising i) a first set of one or more containers, each container containing a vaccine composition for intranasal administration, b) optionally a second vaccine component comprising a second set of one or more containers, each container containing a vaccine composition for intranasal administration, wherein each container of the first and second set of containers contains a total volume of the vaccine composition from about 5 microliter to about 400 microliter for immunizing a human. The use of: a) a first vaccine component comprising i) a first set of one or more containers, each container containing a vaccine composition for intranasal administration, b) optionally a second vaccine component comprising a second set of one or more containers, each container containing a vaccine composition for intranasal administration, wherein each container of the first and second set of containers contains a total volume of the vaccine composition from about 5 microliter to about 400 microliter for the preparation of a vaccine for intranasally immunizing a human. The method of treating a person in need of a vaccination. The vaccine formulated for intranasal administering.
Public/Granted literature
- US20160184424A1 INTRANASAL VACCINATION DOSAGE REGIMEN Public/Granted day:2016-06-30
Information query